Related Experiment Video
Updated: Mar 22, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
De novo protein assembly enables drug-controlled cellular functions
Chenxin Wu1, Chuan Shan1, Lei Lu1
1School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
None:
Chemically induced oligomerization represents a powerful mechanism for regulation of protein activity. In a recently published article in Science, Jin et al.1 demonstrate that the FDA-approved drug amantadine can induce assembly of de novo designed proteins. Applications in transcriptional control, protein condensation, and localization highlight the translational potential of this approach in biotechnology and health.
Related Concept Videos
Regulation of Expression at Multiple Steps
Biosynthesis of Nucleic Acids
Prodrugs
Prodrugs help overcome...
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...

